The Federal Trade Commission (FTC) doled out fines totaling $29.5 million to four manufacturers of the over-the-counter weight loss medications Cortislim, Xenadrine EFX, TrimSpa and One-A-Day WeightSmart for making false claims about their products. The FTC found that these products were primarily a combination of caffeine, herbs and vitamins and did little or nothing to induce weight loss, particularly of the magnitude claimed in advertising for the products. A study by the manufacturer of Xenadrine found that participants taking placebo lost more weight than those on Xenadrine, but this finding went unreported in their advertising. People who purchased these medications may qualify for reimbursement through the FTC web site.
January 5th, 2009 Posted by: